Cannabis extract trial aims to ease autism symptoms in kids
NCT ID NCT07257939
First seen Dec 29, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tests whether a full-spectrum cannabis plant extract called NTI164 can help reduce core autism symptoms like social difficulties and repetitive behaviors. About 98 children and young adults aged 6 to 25 with moderate to severe autism will receive either NTI164 or a placebo for 16 weeks. Researchers will measure changes using standard surveys and blood tests to see if the treatment is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Monash Health
Clayton, Victoria, 3168, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.